Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05215132 · ClinicalTrials.gov registry record · Phase 4
Investigational MRI Clinical Software and Hardware
A Phase 4 study of Image, Body, sponsored by Northwestern University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 2,000
- Enrollment target
- 1
- Study location
NCT05215132: Recruiting Phase 4 study of Image, Body, sponsored by Northwestern University.
NCT05215132 is a Phase 4 study of Image, Body that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 2,000 participants, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (286% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05215132, a Phase 4 study of Image, Body, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Patients and healthy volunteers will be scanned in order to test new sequences.
Primary Outcome
Testing of new MRI pulse sequences will be performed for validation of potential new diagnostic capabilities. The MRI pulse sequences will be routinely performed along with clinically-validated and accepted pulse sequences for comparison of the novel sequences in human subjects (patients and healthy volunteers). Novel sequences will be performed in the accepted method with adjustment of settings to evaluate image qualities and normative values produced by the MRI machine. The resulting images pr
Conditions Studied
Interventions
- RADIATION MRI
- DRUG Gadavist 2Ml Solution for Injection
Study Locations (1)
Illinois
- Northwestern University- Feinberg School of Medicine - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2019-12-19 |
| Est. Completion | 2026-01-31 |
| Phase | Phase 4 |
What NCT05215132 shows while recruiting
NCT05215132 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (286% higher).
The record links to 1 condition, with Image, Body appearing as the primary indexed condition, and to 2 interventions - of which MRI is the first listed.
NCT05215132 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05215132 about?
NCT05215132 is a clinical study titled "Investigational MRI Clinical Software and Hardware". Patients and healthy volunteers will be scanned in order to test new sequences.
What is the current status of trial NCT05215132?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 2,000 participants. The study started on 2019-12-19. Estimated completion is 2026-01-31.
What conditions does trial NCT05215132 study?
This clinical trial studies the following conditions: Image, Body.
What interventions are being tested in trial NCT05215132?
The interventions under investigation include: MRI (RADIATION), Gadavist 2Ml Solution for Injection (DRUG).
Who is sponsoring clinical trial NCT05215132?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05215132 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Image, Body
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05215132's enrollment target sits among peer trials
2,000 37th of 2000 higher than 1,959 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI